JAN 21, 2020 2:57 PM PST

Repurposing Existing Drugs to Treat Cancer

WRITTEN BY: Carmen Leitch

Even after the complicated task of drug development, pharmaceuticals have to be rigorously tested before they can be offered to patients, so it can be much easier to find more than one application for an existing medication. Scientists have now tested a wide variety of drugs that are used to treat many different conditions to see if they had any anti-cancer effect. They were surprised to find that nearly fifty of the ones they assessed, including drugs for alcoholism, diabetes, inflammation, and pet medication for arthritis, exhibited anti-cancer activity that was previously unknown. The work has been reported in Nature Cancer.

"We thought we'd be lucky if we found even a single compound with anti-cancer properties, but we were surprised to find so many," said Professor Todd Golub, chief scientific officer and director of the Cancer Program at the Broad Institute of MIT and Harvard, and Charles A. Dana Investigator in Human Cancer Genetics at Dana-Farber.

This work utilized a collection of around 6,000 drugs that have either been proven to be safe in clinical trials or are approved by the Food and Drug Administration; it's called the Drug Repurposing Hub. The researchers tagged 578 human cancer cell lines with DNA barcodes so the vast number of cells could be pooled and exposed to the many medications. The survival rate of the various cancer cells was measured so the investigators could determine which of the drugs kill cancer.

"We created the repurposing hub to enable researchers to make these kinds of serendipitous discoveries in a more deliberate way," said the first author of the study Steven Corsello, an oncologist at Dana-Farber and founder of the Drug Repurposing Hub.

The researchers discovered the anti-cancer activity of fifty drugs, some of which killed selectively, while others destroyed cancer cells in surprising ways.

"Most existing cancer drugs work by blocking proteins, but we're finding that compounds can act through other mechanisms," said Corsello. Some of these drugs don't work by interfering with a protein; they stabilize a chemical interaction or activate a protein, for example. This cell-survival-based approach made identifying these mechanisms easier, said Corsello.

Image credit: Pixabay

In another case, cancer cells were killed by drugs that interacting with something unknown. For example, tepoxalin is used to treat osteoarthritis in dogs, and this anti-inflammatory medication kills cancer after acting on an unknown target in cells that express high levels of a protein called MDR1.

Genetic characteristics like methylation levels and mutations in the cancer cell lines enabled the researchers to predict which drugs would kill them. For example, cells that carried mutations that reduced their metallothionein protein levels were killed by a drug for alcohol dependence, called Antabuse. If cells expressed a certain sulfate transporter called SLC26A2, they were susceptible to drugs that contain vanadium.

"The genomic features gave us some initial hypotheses about how the drugs could be acting, which we can then take back to study in the lab," said Corsello. "Our understanding of how these drugs kill cancer cells gives us a starting point for developing new therapies. This is a great initial dataset, but certainly, there will be a great benefit to expanding this approach in the future."

Sources: AAAS/Eurekalert! via Broad Institute of MIT and Harvard, Nature Cancer

About the Author
  • Experienced research scientist and technical expert with authorships on over 30 peer-reviewed publications, traveler to over 70 countries, published photographer and internationally-exhibited painter, volunteer trained in disaster-response, CPR and DV counseling.
You May Also Like
SEP 11, 2020
Drug Discovery & Development
Single Injection Sends Type 2 Diabetes into Remission
SEP 11, 2020
Single Injection Sends Type 2 Diabetes into Remission
Type 2 diabetes affects around 10% of people in the US. Although there is no cure for it, there are some well-known meth ...
SEP 11, 2020
Immunology
Study Reveals Tumor Defense Mechanism... And How to Beat It
SEP 11, 2020
Study Reveals Tumor Defense Mechanism... And How to Beat It
  P53 is an infamous process gene at the core of the development of tumors.  When P53  functional, it pau ...
OCT 19, 2020
Clinical & Molecular DX
Making Capillary Electrophoresis Accessible for Any Lab
OCT 19, 2020
Making Capillary Electrophoresis Accessible for Any Lab
Analyzing nucleic acids through gel electrophoresis has been a staple of genetic research for decades. But using traditi ...
OCT 06, 2020
Cell & Molecular Biology
How a Carnivorous Plant Creates a 'Memory'
OCT 06, 2020
How a Carnivorous Plant Creates a 'Memory'
The Venus flytrap (Dionaea muscipula) is a famous carnivorous plant that can capture and consume insects and even small ...
OCT 26, 2020
Cell & Molecular Biology
When Exposed to Estrogen, Fish Generate Fewer Males
OCT 26, 2020
When Exposed to Estrogen, Fish Generate Fewer Males
Life on earth relies on clean water, something that is becoming more scarce. Researchers have found that if water is con ...
NOV 11, 2020
Cell & Molecular Biology
Visualizing a Tumor Suppressor in Action
NOV 11, 2020
Visualizing a Tumor Suppressor in Action
Many types of cells in our bodies are short-lived and need to be replenished. Cell division has to be carefully controll ...
Loading Comments...